Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus

January 29, 2019 6:46 AM

Pfizer (NYSE: PFE) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the consensus estimate of $13.91 billion.


Pfizer sees FY2019 EPS of $2.82-$2.92, versus the consensus of $3.04. Pfizer sees FY2019 revenue of $52-54 billion, versus the consensus of $54.36 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.


Earnings Guidance Hot Earnings Hot Guidance

Next Articles